title: [B-cell lymphoma with concurrent myc/IgH and bcl-2/IgH translocations: report of a case].
authors.forename: Li
authors.initials: L
authors.lastname: Li
authors.forename: Yan-hui
authors.initials: YH
authors.lastname: Liu
authors.forename: Heng-guo
authors.initials: HG
authors.lastname: Zhuang
authors.forename: Dong-lan
authors.initials: DL
authors.lastname: Luo
authors.forename: Fang-ping
authors.initials: FP
authors.lastname: Xu
authors.forename: Xin-lan
authors.initials: XL
authors.lastname: Luo
authors.forename: Jie
authors.initials: J
authors.lastname: Xu
authors.forename: Ke-ping
authors.initials: KP
authors.lastname: Zhang
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D050438:Genes, Immunoglobulin Heavy Chain; D019254:Genes, bcl-2; D016259:Genes, myc; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D014178:Translocation, Genetic; D014750:Vincristine / Q000627:therapeutic use
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone; D008727:Methotrexate